Mark
Cuban

The Man Who Sold the Internet and Went Back for More

By 1999, Mark Cuban had already done the thing most entrepreneurs only dream about - he'd sold a company for more money than he could reasonably spend in a lifetime. Broadcast.com, the internet radio and streaming company he co-founded with Todd Wagner, went to Yahoo for $5.7 billion in stock. It was one of the largest acquisitions of the dot-com era. The next morning, Cuban did not retire to a beach. He bought an NBA franchise.

This is the defining feature of Cuban's operating system: he is constitutionally incapable of coasting. The $285 million he paid for the Dallas Mavericks in January 2000 wasn't a vanity purchase - it was a project. The team had a 40% win rate and an absentee ownership culture. Cuban moved into the arena. He sat in regular fan seats, not the owner's suite. He answered emails from strangers at 2 a.m. He got fined by the NBA thirteen separate times for arguing with referees, and each time matched the fine amount with a charitable donation. By 2011, the Mavericks were NBA Champions.

But the Mavericks chapter only makes sense if you understand where Cuban started. Pittsburgh, 1958. His grandfather arrived from the Russian Empire with the name Chabenisky and left with the name Cuban. Mark grew up in working-class Mount Lebanon, selling garbage bags door-to-door at age twelve - not because he was hustling for sport, but because he wanted basketball shoes. At sixteen he was running newspapers during a strike. At Indiana University he paid tuition by running a bar and teaching disco dancing lessons.

After graduating in 1981 with a management degree, he drove to Dallas with everything he owned. He shared a three-bedroom apartment with five other people and slept on the floor. His first real venture, MicroSolutions, was a systems integration and software reselling company he co-founded in 1982. By 1990, it had $30 million in revenue. He sold it to CompuServe for $6 million - took a two-year sabbatical, then got bored.

The Broadcast.com story is simultaneously a tech fairy tale and a masterclass in knowing when to get off the train. Cuban and Wagner recognized early that the internet would become a distribution channel for audio and video. They built the infrastructure before the mainstream caught on. When Yahoo acquired them in 1999, Cuban immediately began hedging his Yahoo stock position - a decision that preserved billions when the dot-com bubble burst months later. His peers who held on watched their paper fortunes evaporate. Cuban's remained intact.

He used that capital to buy the Mavericks, yes - but also to wire himself into the media business through 2929 Entertainment (which acquired Landmark Theatres, 58 art house cinemas), co-found AXS TV, and pioneer a simultaneous theatrical-DVD-cable distribution model for films that the industry initially mocked and eventually adopted. He financed Steven Soderbergh's Bubble in 2006 as a proof of concept. Hollywood noticed.

Shark Tank and the Pharma War

Shark Tank entered Cuban's life in 2011, Season 2. He did not need the exposure. He joined because the format appealed to something structural in how he thinks: entrepreneurs, real ones, making actual pitches with real stakes. Over sixteen seasons, he wrote checks to more than 85 companies. BeatBox Beverages. Ten Thirty One Productions. Companies that would go nowhere and companies that would grow into something. He treated each deal as a portfolio bet, not a charity grant.

He announced his exit from the show in 2024, with Season 16 as his last. The way he framed it was consistent with his broader worldview: Shark Tank had been useful. Now something more important required his attention.

That something is the Mark Cuban Cost Plus Drug Company, founded in 2022. The premise is straightforward and the execution is radical. American pharmaceutical pricing is not a market - it's a series of negotiated opacity maintained by pharmacy benefit managers, insurance middlemen, and drug manufacturers who have every incentive to keep prices high. Cost Plus Drugs bypasses the entire system, selling generic medications directly to consumers at manufacturing cost plus a small markup.

Cuban calls it a "war on America's $5 trillion healthcare machine." The early evidence suggests the war is making progress. Partnerships with Humana and TrumpRx in 2025 suggest that even institutional players are taking the model seriously. A drug that costs $500 at a pharmacy chain can cost $5 through Cost Plus. For millions of Americans managing chronic conditions, this is not a theoretical difference.

His January 2025 blog post at blogmaverick.com - his first in years - was entirely about healthcare economics. The blog itself is a window into how his mind works: dense, direct, written like a midnight email to a smart friend who can handle the details without a lot of scaffolding.

On AI, he's been more cautious than the current hype cycle might suggest. "AI is never the answer, it's a tool," he said in 2025. He invested in Clipbook, an AI PR startup, after receiving a cold email pitch - a detail worth noting, because it tells you something about how he actually makes decisions. He still reads emails from strangers. He still bets on people he's never met based on the quality of their pitch. The same mechanism that helped him build MicroSolutions in 1982 is still running in 2025.

In March 2026, he told the public what he'd probably known for a while: selling the Mavericks to the Adelson family was a mistake. He didn't elaborate extensively, but the regret was real enough to say out loud. There's something honest about a man with $6 billion admitting that money alone wasn't the point.